BioNeutra Global Corp. (BGA) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

5.0 k

Shareholding (Jun 2023)

FII

0.00%

Held by 0 FIIs

DII

Held by 0 DIIs

Promoter

36.52%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals: Other

Market cap

CAD 2 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.56

Return on Equity

7.41%

Price to Book

-0.25

Revenue and Profits:

Net Sales:

3 Million

(Quarterly Results - Sep 2024)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

0.0%

6 Months

0.0%

1 Year

-70.0%

2 Years

100.0%

3 Years

-78.57%

4 Years

-88.24%

5 Years

-88.0%

BioNeutra Global Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-21.01%

EBIT Growth (5y)

14.59%

EBIT to Interest (avg)

-3.22

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.56

Sales to Capital Employed (avg)

-2.38

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-0.25

EV to EBIT

-6.68

EV to EBITDA

6.68

EV to Capital Employed

-1.83

EV to Sales

0.62

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bullish

No Signal

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

No Trend

Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2023

Shareholding Compare (%holding)

Majority shareholders

Non Institution

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is 19.23% vs 4.00% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is 50.00% vs 0.00% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3.10",
          "val2": "2.60",
          "chgp": "19.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "-0.40",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.20",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.40",
          "val2": "-0.80",
          "chgp": "50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-91.60%",
          "val2": "-235.40%",
          "chgp": "14.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -14.93% vs -12.99% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 27.59% vs -3.57% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.40",
          "val2": "13.40",
          "chgp": "-14.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.40",
          "val2": "-1.40",
          "chgp": "71.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "0.50",
          "chgp": "40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.10",
          "val2": "-2.90",
          "chgp": "27.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-129.60%",
          "val2": "-184.20%",
          "chgp": "5.46%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ

Sep'24

Jun'24

Change(%)

Net Sales

3.10

2.60

19.23%

Operating Profit (PBDIT) excl Other Income

-0.20

-0.40

50.00%

Interest

0.20

Exceptional Items

0.00

Consolidate Net Profit

-0.40

-0.80

50.00%

Operating Profit Margin (Excl OI)

-91.60%

-235.40%

14.38%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2024 is 19.23% vs 4.00% in Jun 2024

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2024 is 50.00% vs 0.00% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

11.40

13.40

-14.93%

Operating Profit (PBDIT) excl Other Income

-0.40

-1.40

71.43%

Interest

0.70

0.50

40.00%

Exceptional Items

0.00

Consolidate Net Profit

-2.10

-2.90

27.59%

Operating Profit Margin (Excl OI)

-129.60%

-184.20%

5.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is -14.93% vs -12.99% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 27.59% vs -3.57% in Dec 2022

All Annual Results

Company CV

About BioNeutra Global Corp.

BioNeutra Global Corp.

Pharmaceuticals: Other

BioNeutra Global Corporation is engaged in the research and development, production and commercialization of food ingredients for neutraceutical, functional and mainstream foods. The Company focuses on oligosaccharides. The Company's product, VitaFiber, which is a functional and health food ingredient made from agricultural products. The Company produces VitaFiber using its processes that transforms starch molecules from agriculture cereal crops, including corn, wheat, barley, potato, or tapioca into the functional health molecules of isomalto-oligosaccharide (IMO). The Company's VitaFiber is a sweet fiber, providing low calorie and soluble prebiotic fiber for human digestive health and it is also non-genetically modified organisms (GMO), sugar-free and gluten-free. The Company's VitaFiber-IMO products include a dietary fiber, a prebiotic, manages gastrointestinal health and a low calorie health sweetener.

Company Coordinates

Company Details

9608 - 25 Avenue NW , EDMONTON AB : T6N 1J4

Tel: 1 780 4661481

http://bioneutra.ca/

Registrar Details